Walker Meghan J, Mirea Lucia, Glendon Gord, Ritvo Paul, Andrulis Irene L, Knight Julia A, Chiarelli Anna M
Prevention and Cancer Control, Cancer Care Ontario, Toronto, Ontario, Canada; Division of Epidemiology, Dalla Lana School of Public Health, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Division of Biostatistics, Dalla Lana School of Public Health, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Maternal-Infant Care Research Centre, Mount Sinai Hospital, Toronto, Ontario, Canada.
Breast. 2014 Aug;23(4):482-8. doi: 10.1016/j.breast.2014.04.001. Epub 2014 May 10.
While the relationship between perceived risk and breast cancer screening use has been studied extensively, most studies are cross-sectional. We prospectively examined this relationship among 913 women, aged 25-72 with varying levels of familial breast cancer risk from the Ontario site of the Breast Cancer Family Registry. Associations between perceived lifetime breast cancer risk and subsequent use of mammography, clinical breast examination (CBE) and genetic testing were assessed using logistic regression. Overall, perceived risk did not predict subsequent use of mammography, CBE or genetic testing. Among women at moderate/high familial risk, those reporting a perceived risk greater than 50% were significantly less likely to have a CBE (odds ratio (OR) = 0.52, 95% confidence interval (CI): 0.30-0.91, p = 0.04), and non-significantly less likely to have a mammogram (OR = 0.70, 95% CI: 0.40-1.20, p = 0.70) or genetic test (OR = 0.61, 95% CI: 0.34-1.10, p = 0.09) compared to women reporting a perceived risk of 50%. In contrast, among women at low familial risk, those reporting a perceived risk greater than 50% were non-significantly more likely to have a mammogram (OR = 1.13, 95% CI: 0.59-2.16, p = 0.78), CBE (OR = 1.11, 95% CI: 0.63-1.95, p = 0.74) or genetic test (OR = 1.29, 95% CI: 0.50-3.33, p = 0.35) compared to women reporting a perceived risk of 50%. Perceived risk did not significantly predict screening use overall, however this relationship may be moderated by level of familial risk. Results may inform risk education and management strategies for women with varying levels of familial breast cancer risk.
虽然感知风险与乳腺癌筛查使用之间的关系已得到广泛研究,但大多数研究都是横断面研究。我们对来自乳腺癌家族登记处安大略站点的913名年龄在25至72岁之间、具有不同程度家族性乳腺癌风险的女性进行了前瞻性研究,以考察这种关系。使用逻辑回归评估了感知终身乳腺癌风险与随后进行乳房X线摄影、临床乳房检查(CBE)和基因检测之间的关联。总体而言,感知风险并不能预测随后进行乳房X线摄影、CBE或基因检测的情况。在中度/高度家族风险的女性中,那些报告感知风险大于50%的女性进行CBE的可能性显著降低(优势比(OR)=0.52,95%置信区间(CI):0.30 - 0.91,p = 0.04),进行乳房X线摄影(OR = 0.70,95%CI:0.40 - 1.20,p = 0.70)或基因检测(OR = 0.61,95%CI:0.34 - 1.10,p = 0.09)的可能性与报告感知风险为50%的女性相比虽未显著降低,但也有一定程度减少。相比之下,在低家族风险的女性中,那些报告感知风险大于50%的女性进行乳房X线摄影(OR = 1.13,95%CI:0.59 - 2.16,p = 0.78)、CBE(OR = 1.11,95%CI:0.63 - 1.95,p = 0.74)或基因检测(OR = 1.29,95%CI:0.50 - 3.33,p = 0.35)的可能性与报告感知风险为50%的女性相比虽未显著增加,但也有一定程度升高。总体而言,感知风险并不能显著预测筛查的使用情况,然而这种关系可能会受到家族风险水平的调节。研究结果可能为不同家族性乳腺癌风险水平的女性的风险教育和管理策略提供参考。